Nirsevimab implementation in Catalonia, Spain, reduced emergency department visits and hospital admissions for bronchiolitis ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.

A single injection of nirsevimab, a long-acting monoclonal antibody developed to prevent respiratory syncytial virus (RSV) ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

The 9-year-old Harborcreek Township girl used to run around with the other kids on the Rolling Ridge Elementary School ...

New research suggests that early impairment in mucosal IgA immunity may contribute to the later development of bronchiolitis ...

RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, according to the United Nation health body ...

Pediatric research explored environmental interventions for bronchiolitis, heart function in children born preterm, and a ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

A panelist discusses how axatilimab is particularly effective for patients with bronchiolitis obliterans syndrome, showing ...